Human and viral interleukin-10 in Hodgkin's disease, and its influence on CD4+ and CD8+ T lymphocytes
- 4 July 1995
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 62 (1), 5-10
- https://doi.org/10.1002/ijc.2910620103
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The epstein‐barr virus latent membrane protein‐1 (LMP1) induces interleukin‐10 production in burkitt lymphoma linesInternational Journal of Cancer, 1994
- Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus.Journal of Clinical Investigation, 1994
- Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus.The Journal of Experimental Medicine, 1993
- Description of an In Situ Hybridization Methodology for Detection of Epstein-Barr Virus RNA in Paraffin-Embedded Tissues, with a Survey of Normal and Neoplastic TissuesDiagnostic Molecular Pathology, 1992
- Role of T Cells in the Pathogenesis of Hodgkin's DiseasePublished by Elsevier ,1992
- Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.The Journal of Experimental Medicine, 1991
- Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells.Proceedings of the National Academy of Sciences, 1991
- Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformantsNature, 1988
- Natural killer cell activity during the course of disease in patients with Hodgkin's diseaseCancer, 1985
- DNA sequence and expression of the B95-8 Epstein—Barr virus genomeNature, 1984